Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute
05-11-2020
pichetw / Shutterstock.com
Healthcare company Abbott Laboratories has agreed to divest two medical device businesses in a bid to settle competition charges brought by the US Federal Trade Commission (FTC).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Abbott Laboratories, St Jude Medical, Mergers & Acquisitions, FTC, Federal Trade Commission, anticompetitive, divest, medical devices
